Parma, Italy

Stefano Levanto

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Levanto. Retrieved from https://idiyas.com/inventor/stefano-levanto-g3dj8y1b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stefano Levanto

Introduction

Stefano Levanto is an inventor based in Parma, Italy. He is currently associated with Chiesi Farmaceutici S.p.a., where he contributes to the field of pharmaceutical innovations. Although he has not yet been granted any patents, his work focuses on developing compounds that may have significant therapeutic applications.

Latest Patent Applications

Stefano Levanto has been involved in several notable patent applications. One of his latest applications is titled "Pyrrolidine Derivatives as DDRs Inhibitors." This invention relates to compounds that inhibit Discoidin Domain Receptors (DDR inhibitors). It includes methods for preparing these compounds, intermediate compounds useful in such preparations, and pharmaceutical compositions containing them. The therapeutic use of these compounds may be beneficial in treating various disorders associated with DDR mechanisms.

Another significant application is "Tetrahydrothieno Pyridine Derivatives as DDRs Inhibitors." Similar to the previous application, this invention also focuses on compounds that inhibit DDRs. It outlines methods for preparing these compounds, pharmaceutical compositions, and their potential therapeutic uses in treating disorders linked to DDR mechanisms.

Conclusion

Stefano Levanto is an emerging inventor in the pharmaceutical field, working on innovative compounds that target critical biological mechanisms. His contributions may pave the way for new therapeutic options in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…